NFKBIZ Produkte
(Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells Inhibitor, zeta (NFKBIZ))
Kategorien
This gene is a member of the ankyrin-repeat family and is induced by lipopolysaccharide (LPS). The C-terminal portion of the encoded product which contains the ankyrin repeats, shares high sequence similarity with the I kappa B family of proteins. The latter are known to play a role in inflammatory responses to LPS by their interaction with NF-B proteins through ankyrin-repeat domains. Studies in mouse indicate that this gene product is one of the nuclear I kappa B proteins and an activator of IL-6 production. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte NFKBIZ Kategorien
NFKBIZ Antikörper
High quality antibodies with extensive validation data.
NFKBIZ ELISA Kits
Reliable ELISA kits for a wide range of species.
NFKBIZ Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene NFKBIZ Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Applikation
WB
Validierungen
- (1)
Kat. Nr.
ABIN6144590
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Bat, Cow, Dog, Horse, Human, Monkey, Mouse, Pig, Rabbit, Rat
Applikation
WB
Validierungen
- (1)
Kat. Nr.
ABIN208547
Menge
0.1 mg
Datenblatt
Datenblatt
Reaktivität
Mouse
Applikation
WB
Validierungen
- (1)
Kat. Nr.
ABIN537379
Menge
100 μg
Datenblatt
Datenblatt
Empfohlene NFKBIZ ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Analytical Method
Validierungen
Kat. Nr.
ABIN1145050
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Mouse
Analytical Method
Sandwich ELISA
Validierungen
Kat. Nr.
ABIN425457
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Cow
Analytical Method
Validierungen
Kat. Nr.
ABIN1145049
Menge
96 tests
Datenblatt
Datenblatt
Empfohlene NFKBIZ Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Source
Wheat germ
Validierungen
- (1)
Kat. Nr.
ABIN1312502
Menge
10 μg
Datenblatt
Datenblatt
Reaktivität
Mouse
Source
Tobacco (Nicotiana tabacum)
Validierungen
- (1)
Kat. Nr.
ABIN3137235
Menge
1 mg
Datenblatt
Datenblatt
Reaktivität
Human
Source
Tobacco (Nicotiana tabacum)
Validierungen
- (1)
Kat. Nr.
ABIN3093091
Menge
1 mg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren NFKBIZ Produkten
: "Dynamics of the Transcriptome during Human Spermatogenesis: Predicting the Potential Key Genes Regulating Male Gametes Generation." in: Scientific reports, Vol. 6, pp. 19069, (2016) (PubMed).: "A mix of S and ΔS variants of STAT3 enable survival of activated B-cell-like diffuse large B-cell lymphoma cells in culture." in: Oncogenesis, Vol. 4, pp. e184, (2016) (PubMed).
Synonyme und alternative Namen zu NFKBIZ
NFKB inhibitor zeta (Nfkbiz), NFKB inhibitor zeta (NFKBIZ), nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta (nfkbiz), NFKB inhibitor zeta (nfkbiz), nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta (Nfkbiz), AA408868, IKBZ, INAP, MAIL, Mail, NFKBIZ, RGD1310834Bezeichner auf Proteinebene für NFKBIZ
- IkappaB-zeta
- NF-kappa-B inhibitor zeta
- nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
- molecule associated with ankyrin repeats induced by lipopolysaccharide
- NF-kappa-B inhibitor zeta-like
- I-kappa-B-zeta
- IL-1 inducible nuclear ankyrin-repeat protein
- ikB-zeta
- ikappaBzeta
- molecule possessing ankyrin repeats induced by lipopolysaccharide
- molecule possessing ankyrin-repeats induced by lipopolysaccharide
- Ikappa B-zeta variant 3
- molecule possessing ankyrin repeats induced by lipopolysaccharide (MAIL), homolog of mouse
Sie sind hier:
